Key facts
- Vynca’s last known valuation is $77.9M (Dec 2021).
- It has raised $50.5M; the latest was Later Stage VC ($5.6M) in Jan 2025.
- Notable investors include MedTech Innovator, StartX (US), First Trust Capital Partners, Equitage Ventures, Link-age Launch — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Vynca
- ·The full record, as it builds
Funding rounds
No funding rounds for Vynca are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vynca
Developer of a health information exchange platform designed to create, store, and share advanced care planning details. The company's platform offers advanced care technology related to health systems, acute care, and post-acute care facilities, along with enhanced care management, and provides patient education and documentation, enabling patients to make end-of-life care choices, manage their ongoing symptoms, and navigate the complex healthcare system.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2014
- Employees
- 151
- Website
- vyncacare.com/
- Ownership
- Privately Held (backing)
Vynca doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vynca shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vynca in its N-PORT filings yet. We sweep new filings monthly.